The latter years contribute very little to NPV due to compounded discounting. It is highly sensitive to capex of course as it is incurred upfront.
You can replicate the results approximately by punching in -2000, +100 (ramp up), +250 (ramp up) and then +400 thereafter (steady stage, roughly 550 less tax).
- Forums
- ASX - By Stock
- QPM
- Ann: TECH Project Feasibility Study
Ann: TECH Project Feasibility Study, page-285
-
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QPM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.3¢ | $255.5K | 7.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 749999 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 675468 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 749999 | 0.034 |
11 | 1375659 | 0.033 |
12 | 3292967 | 0.032 |
7 | 1598958 | 0.031 |
10 | 792998 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 675468 | 3 |
0.036 | 790884 | 8 |
0.037 | 910393 | 4 |
0.038 | 598000 | 3 |
0.039 | 500000 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
QPM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online